This Solicitation opportunity from District of Columbia was posted on December 12, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

FEMS Logistics Medical Supplies & Pharmaceuticals

Closed

Doc803704State & Local

Submission Closed12/18/2025, 12:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

SUNSCREEN PREPARATIThe contract pertains to the procurement of SUNSCREEN PREPARATI with the NSN/Part Number 6505-01-657-9247, submitted under Purchase Request 7017191874 for a quantity of one unit. The solicitation, identified by number SPE2DP-26-T-3818, was posted on June 24, 2026, with a response deadline of June 29, 2026. It falls under the NAICS code 325412, which corresponds to the manufacturing of other pharmaceutical and medicinal products. The responsible agency is the Defense Logistics Agency, operating under the Department of Defense, indicating this is a federal procurement aimed at meeting military or defense-related needs. The place of performance and point of contact details are unspecified, and the solicitation does not indicate a specific set-aside type. Interested parties must respond through the official DIBBS portal using the provided UI link before the deadline.

Defense Logistics Agency

POSTED

DEADLINE

CARPROFEN TABLETSThe contract pertains to the procurement of CARPROFEN TABLETS under solicitation number SPE2DP-26-T-3908, issued by the Defense Logistics Agency on behalf of the Department of Defense. The solicitation was posted on June 24, 2026, with a response deadline of June 30, 2026, and requests a single unit with the NSN or part number 6509-01-487-4464. The transaction falls under a federal procurement category with no specified set-aside designation or NAICS code, indicating a standard open competition for a single-item requirement. The place of performance and organizational details are not fully specified, but the contracting authority operates under U.S. federal jurisdiction. All communication and response must be submitted through the official DIBBS platform linked in the documentation.

Defense Logistics Agency

POSTED

DEADLINE

Biomanufacturing Process DevelopmentThe contract seeks to advance scalable biomanufacturing processes by engineering microbes or enzymatic systems to produce hierarchical biocomposites with high reproducibility and optimized yield. The effort focuses on developing robust biological platforms capable of consistent large-scale production of advanced materials with complex structural hierarchies, targeting applications where performance, sustainability, and manufacturability are critical. Success requires integrating synthetic biology, metabolic engineering, and process engineering to ensure biological systems deliver targeted material properties under industrial conditions. This is a small business set-aside solicitation under the SBA’s SBIR/STTR mandate, restricted to organizations with fewer than 500 employees, and is classified under NAICS code 325412 for biotechnology manufacturing. Issued by the Defense Advanced Research Projects Agency under the U.S. Department of Defense, the proposal must be submitted by July 8, 2026, with the solicitation posted on June 24, 2026. The project is structured as a subcontract and aims to accelerate the transition of biomanufacturing technologies from lab-scale innovation to viable production systems aligned with defense and national security needs.

Defense Advanced Research Projects Agency

POSTED

DEADLINE

Azithromycin Tablets SolicitationThe solicitation for Azithromycin Tablets, identified by solicitation number SPE2D2-26-R-0008, is a firm-fixed-price requirements contract issued by the Defense Logistics Agency Troop Support under NAICS code 325412, aiming to procure multiple dosage forms of Azithromycin tablets—including 250 mg, 500 mg, and 600 mg strengths in various bottle counts—primarily for use by DoD, VA, BoP, and IHS medical facilities through Prime Vendor (PPV) contractors. The contract envisions a one-year base period with four option years, potentially extending the total performance period to five years, and requires the contractor to fulfill orders within 15 calendar days of receipt and be operational for fulfillment no later than 45 days after award, with FOB Destination terms applying. All products must meet stringent packaging criteria: glass bottles are prohibited, each unit must contain a childproof safety cap, and bottles must be cylindrical with a minimum 100cc volume and 5.75-inch circumference to accommodate standardized labeling. Bar code requirements are highly specific, mandating linear HIBC or GS1-128 compliance at the unit-of-use level, with expiration date and lot number encoded, proper quiet zones, ladder orientation on vials, and no printing across blister pack perforations, all while ensuring a minimum barcode quality grade of C per ANSI, ISO, or IEC standards. The contract also enforces strict compliance with the Trade Agreements Act, requiring full disclosure of the country of origin for both the finished product and its active pharmaceutical ingredients, with FDA approval via NDA, ANDA, or BLA mandatory for all offered drugs. The solicitation explicitly states that Amendment 3 removed line item 5 from the original schedule, requiring proposers to reference the updated schedule of supplies on page 5. Proposals must be submitted exclusively via the DIBBS platform by June 16, 2026, at 3:00 PM ET, and must be organized into two volumes: the first containing the signed SF 1449, full solicitation documentation, and a detailed Trade Agreements chart identifying country-of-origin for all end products and APIs; the second containing pricing data for line items 0001–0005. Offerors must be registered in SAM with current representations and certifications—including those related to defense telecommunications prohibitions, economic price adjustments,

POSTED

DEADLINE

6505--RFI - DRAFT SOW for PPV 2028 Amendment to Extend Response Date from July 2, 2026 to July 10, 2026 11:00AM CT.The Department of Veterans Affairs is conducting an industry engagement initiative to gather feedback on the draft Statement of Work for the Pharmaceutical Prime Vendor 2028 acquisition, with a revised response deadline of July 10, 2026, at 11:00 AM Central Time. This request is not a solicitation and does not obligate the government to issue a future contract or make an award; participation is voluntary and intended solely to refine requirements and improve the quality of the final SOW. Industry participants are invited to comment on clarity, technical feasibility, operational challenges, and alignment with best practices across distribution, inventory management, reporting, data exchange, and order fulfillment. Feedback must include the company name, point of contact details, UEI and CAGE codes, and socioeconomic designations if applicable, and should be submitted to Karen Ade at Karen.Ade@va.gov. The NAICS code associated with this effort is 325412, and the contract will be administered by the VA National Acquisition Center based in Hines, Illinois. The Pharmaceutical Prime Vendor 2028 contract will require the vendor to distribute all pharmaceutical products under Federal Supply Class 65 to VA medical centers, satellite facilities, CMOPs, and IHS locations, including overseas sites. Key obligations include maintaining electronic ordering and paperless invoicing systems, managing supplier back orders and stockouts, handling product recalls, and ensuring compliance with the Veterans Health Care Act of 1992 by adhering strictly to the Federal Ceiling Price for covered drugs. Pricing structures are defined across multiple line items for brand and generic pharmaceuticals, specialty products, and WAC-based generics, each with FastPay and Net 30 payment terms, and all prices must include a 0.25% Cost Recovery Fee. The vendor must comply with the Drug Supply Chain Security Act by providing full transaction data for covered transactions and deploying the D barcode standard, and must also meet Trade Agreements Act requirements by tracking and reporting non-TAA compliant products weekly. Packaging requirements mandate hazardous drugs be segregated in impervious plastic and clearly labeled as NIOSH Hazardous Drug, with all pallets bearing permanent, human-readable and 2D barcode labels containing critical information such as CMOP station number, PO number, invoice number, drug name, and quantity. A 120-day transition period follows award before formal performance begins, and the contract includes a base period with three one-year option periods. The vendor must maintain current state and federal licenses,

Nac Prime Vendor (36W797)

POSTED

1 day ago

DEADLINE

in 15 days

General Info

Agency

District of Columbia → D.C. Fire and Emergency Services DepartmentView Agency

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

DC, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedDec 12

Solicitation

Response DeadlineDec 18

Deadline has passed

Submission Closed

12/18/2025, 12:00:00 AM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDistrict of Columbia → D.C. Fire and Emergency Services Department

Contacts1 person available

OfficeN/A

Organization / Agency

District of Columbia → D.C. Fire and Emergency Services Department

View Agency Profile

Office AddressN/A

Contacts

Lorena Marko

contact@example.gov